---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-211946"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:02:02.580828+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare Q1 revenue $55.9M (-6% YoY); net loss $192.4M on $197M goodwill impairment

## Summary
- Revenue of $55.9M, at top end of guidance, down 6% from $59.2M in Q1 2025.
- Net loss of $(192.4)M includes $197.2M goodwill impairment; adjusted net income rose to $8.5M from $7.0M.
- Adjusted EBITDA $15.3M (27% margin) vs $14.7M (25%) YoY; operating cash flow $11.6M, unlevered FCF $18.0M.
- Q2 2026 guidance: revenue $55-56M, adj. EBITDA $13.5-14.5M. Full-year: revenue $220-226M, adj. EBITDA $55-59M.
- Customer wins include a six-figure multi-year life sciences deal and Monocl expansion from a biopharma acquisition.

## SEC filing metadata
- accession: 0001193125-26-211946
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000119312526211946/0001193125-26-211946-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000119312526211946/dh-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-211946
- JSON: https://secwatch.observer/filing/0001193125-26-211946.json
- Plain text: https://secwatch.observer/filing/0001193125-26-211946.txt

## Source-grounded claims
- claim_id: e79b5c3cdbbab9e77a9907bfb0abe78a96e36b91
  claim: Definitive Healthcare Corp. reported Q1 2026 results: revenue $55.9 million, net income $(192.4) million.
  evidence_excerpt: First Quarter 2026 Financial Highlights: • Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. • Net Loss , inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000119312526211946/0001193125-26-211946-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.